OSINT – Telegram
https://www.sciencedirect.com/science/article/pii/S1473309921004850

The negative French Randomized Controlled Trial on Remdesivir (n=857)

"No clinical benefit observed from the use of remdesivir in hospitalised patients, symptomatic for more than 7 days, on oxygen support."
This media is not supported in your browser
VIEW IN TELEGRAM
RN speaks out about the ineffectiveness and physiological consequences of prolonged mask-wearing.